The Business Research Company published its Lateral Flow Immunoassay (LFIA) Based Rapid Test Global Market Report 2020 which provides strategists, marketers and senior management with the critical information they need to assess the global Lateral Flow Immunoassay (LFIA) Based Rapid Test market. The report provides in-depth analysis of the impact of COVID-19 on the market, along with revised market numbers due to the effects of the coronavirus.
The report covers the lateral flow immunoassay (LFIA) based rapid test market’s segments-
1) By Technique: Competitive Assay, Sandwich Assay, Multiplex Detection Assay
2) By End User: Hospital and Clinic, Diagnostic Laboratory, Home Care, Others
3) By Application: Infectious Disease, Pregnancy and Fertility, Toxicology, Others.
View Complete Report:
Lateral Flow Immunoassay (LFIA) Based Rapid Test Global Market Report 2020 is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies. The chapter on the impact of COVID-19 gives valuable insights on supply chain disruptions, logistical challenges, and other economic implications of the virus on the market. The chapter also covers markets which have been positively affected by the pandemic.
The global lateral flow immunoassay based rapid test market is expected to decline from $5.98 billion in 2019 to $5.77 billion in 2020 at a compound annual growth rate (CAGR) of -3.63%. The decline is mainly due to the COVID-19 outbreak that has led to restrictive containment measures involving social distancing, remote working, and the closure of industries and other commercial activities. The entire supply chain has been disrupted, impacting the market negatively. The market is then expected to recover and reach $7.54 billion in 2023 at a CAGR of 9.36%.
The demand for point-of-care testing under home care settings is expected to drive the LFIA based rapid test market. Point-of-care (POCT) testing is essential for rapid on-site diagnosis and treatment. The most important features for current POCT diagnostic systems are a quick analysis time with a test-to-answer format. LFIA are widely used as POCTs due to their speed and precision, simplicity and low cost.
Few Points From Table Of Content
- Executive Summary
- Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Characteristics
- Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Size And Growth
- Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Segmentation
- Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Regional And Country Analysis
....
- Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Competitive Landscape And Company Profiles
- Key Mergers And Acquisitions In The Lateral Flow Immunoassay (LFIA) Based Rapid Test Market
- Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Trends And Strategies
- Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Future Outlook and Potential Analysis
- Appendix
Request A Sample Report At: https://www.thebusinessresearchcompany.com/sample.aspx?id=3293&type=smp
Few Points From List Of Tables
Table 1: Global Historic Market Growth, 2015-2019, $ Billion
Table 2: Global Forecast Market Growth, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 3: Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 4: Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
………
Table 28: F. Hoffmann-La Roche Financial Performance
Table 29: Danaher Corporation Financial Performance
Table 30: Siemens AG Financial Performance
Table 31: Becton, Dickinson and Company Financial Performance
About The Business Research Company:
The Business Research Company is a Business Intelligence Company which excels in company, market and consumer research. It has offices in the UK, the US and India and a network of trained researchers in 52 countries globally.
Contact Information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: [email protected]
Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company
The Business Research Company’s latest report Lateral Flow Immunoassay (LFIA) Based Rapid Test Global Market Report 2020 covers Lateral Flow Immunoassay (LFIA) Based Rapid Test market drivers, Lateral Flow Immunoassay (LFIA) Based Rapid Test market trends, Lateral Flow Immunoassay (LFIA) Based Rapid Test market segments, Lateral Flow Immunoassay (LFIA) Based Rapid Test market growth rate, Lateral Flow Immunoassay (LFIA) Based Rapid Test market major players, and Lateral Flow Immunoassay (LFIA) Based Rapid Test market size.
The report provides in-depth analysis of the impact of COVID-19 on the Lateral Flow Immunoassay (LFIA) Based Rapid Test industry, along with revised market numbers due to the effects of the coronavirus.View Complete Report:https://www.thebusinessresearchcompany.com/report/lateral-flow-immunoassay-lfia-based-rapid-test-global-market-report-2020-30-covid-19-growth-and-change Lateral Flow Immunoassay (LFIA) Based Rapid Test Global Market Report 2020 is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies.
The chapter on the impact of COVID-19 gives valuable insights on supply chain disruptions, logistical challenges, and other economic implications of the virus on the market.
The chapter also covers markets which have been positively affected by the pandemic.Request for the sample now:https://www.thebusinessresearchcompany.com/sample.aspx?id=3293=smp The global lateral flow immunoassay based rapid test market is expected to decline from $5.98 billion in 2019 to $5.77 billion in 2020 at a compound annual growth rate (CAGR) of -3.63%.
The decline is mainly due to the COVID-19 outbreak that has led to restrictive containment measures involving social distancing, remote working, and the closure of industries and other commercial activities.
The entire supply chain has been disrupted, impacting the market negatively.
The global Lateral Flow Immunoassay Reader Market research report, published by Value Market Research, is designed to offer various market framework such as market size, portion, trends, growth path, value and factors that impact the current market dynamics over the forecast period 2020-2027.
Most importantly, this report also provides the latest significant strategies adopted by major players along with their market share.The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide.
The major players in the lateral flow immunoassay reader market include Abbott, Abingdon, QIAGEN, BD Company, Axxin, LRE Medical, Detekt Biomedical, Quidel Corporation, Magnasense, Skannex, OpTricon, Fio Corporation, NOWDiagnostics Inc, VICAM, IUL, Mobile Assay, Other.
This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.Get more information on "Global Lateral Flow Immunoassay Reader Market Research Report" by requesting FREE Sample Copy at https://www.valuemarketresearch.com/contact/lateral-flow-immunoassay-reader-market/download-sampleMarket DynamicsThe high demand for rapid test readers that are simple to use, economical, and highly effective in obtaining non-subjective diagnostic test results at hospitals, laboratories, clinics, and other point-of-care locations is the primary stimulant for the growth of this market.
The ability to integrate these readers with a mobile device will be a market booster.
The broad spectrum of testing capabilities provided by these readers and easy integration with LIS and EMR databases will benefit market growth.
Lateral Flow Immunoassay Reader Market report added by Value Market Research, offering growth, trends, and forecast for each segment along with regional and country analysis.
Further, this report also highlights the regional and country-level market analysis.The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide.
The major players in the lateral flow immunoassay reader market include Abbott, Abingdon, QIAGEN, BD Company, Axxin, LRE Medical, Detekt Biomedical, Chembio Diagnostics, Quidel Corporation, Trinity Biotech, Magnasense.
This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.Get more information on "Global Lateral Flow Immunoassay Reader Market Research Report" by requesting FREE Sample Copy at https://www.valuemarketresearch.com/contact/lateral-flow-immunoassay-reader-market/download-sampleMarket DynamicsThe high demand for rapid test readers that are simple to use, economical, and highly effective in obtaining non-subjective diagnostic test results at hospitals, laboratories, clinics, and other point-of-care locations is the primary stimulant for the growth of this market.
The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis.
These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.
